Mabel Graffigna

441 total citations
18 papers, 338 citations indexed

About

Mabel Graffigna is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mabel Graffigna has authored 18 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Epidemiology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mabel Graffigna's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Ovarian function and disorders (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Mabel Graffigna is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Ovarian function and disorders (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Mabel Graffigna collaborates with scholars based in Argentina, United Kingdom and Brazil. Mabel Graffigna's co-authors include Susana Belli, Oscar Levalle, Patricia Otero, León Schurman, Adriana Oneto, Gabriela Berg, Laura Schreier, Verónica Miksztowicz, Alicia Beatriz Motta and Giselle Adriana Abruzzese and has published in prestigious journals such as Fertility and Sterility, Clinica Chimica Acta and Clinical Endocrinology.

In The Last Decade

Mabel Graffigna

16 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mabel Graffigna Argentina 9 130 112 106 105 84 18 338
Maria Alice Neves Bordallo Brazil 11 190 1.5× 70 0.6× 70 0.7× 127 1.2× 38 0.5× 31 403
Cynthia Lamendola United States 11 173 1.3× 49 0.4× 85 0.8× 83 0.8× 100 1.2× 12 464
H Benencia Argentina 7 209 1.6× 50 0.4× 48 0.5× 58 0.6× 31 0.4× 11 317
Rüştü Serter Türkiye 11 123 0.9× 89 0.8× 53 0.5× 50 0.5× 45 0.5× 23 344
Luděk Čížek Czechia 6 106 0.8× 26 0.2× 87 0.8× 57 0.5× 33 0.4× 8 322
Sawaek Weerakiet Thailand 12 71 0.5× 405 3.6× 64 0.6× 269 2.6× 79 0.9× 33 529
Rosanna Suriano Italy 9 138 1.1× 128 1.1× 19 0.2× 101 1.0× 21 0.3× 12 327
Jianhua Han China 9 92 0.7× 22 0.2× 27 0.3× 60 0.6× 28 0.3× 19 323
Jiann‐Loung Hwang Taiwan 17 43 0.3× 306 2.7× 86 0.8× 233 2.2× 42 0.5× 25 550
Jan Neuman Canada 6 164 1.3× 74 0.7× 27 0.3× 46 0.4× 12 0.1× 12 325

Countries citing papers authored by Mabel Graffigna

Since Specialization
Citations

This map shows the geographic impact of Mabel Graffigna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mabel Graffigna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mabel Graffigna more than expected).

Fields of papers citing papers by Mabel Graffigna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mabel Graffigna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mabel Graffigna. The network helps show where Mabel Graffigna may publish in the future.

Co-authorship network of co-authors of Mabel Graffigna

This figure shows the co-authorship network connecting the top 25 collaborators of Mabel Graffigna. A scholar is included among the top collaborators of Mabel Graffigna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mabel Graffigna. Mabel Graffigna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Abruzzese, Giselle Adriana, Juan Manuel Criado Gámez, Susana Belli, et al.. (2020). Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome. Gynecological Endocrinology. 36(12). 1057–1061. 10 indexed citations
2.
Lichtenauer, Michael, Marrissa Martyn‐St James, Michael Duncan, et al.. (2018). Efficacy of anthropometric measures for identifying cardiovascular disease risk in adolescents: review and meta-analysis. Minerva Pediatrics. 70(4). 371–382. 20 indexed citations
3.
Graffigna, Mabel, et al.. (2017). Diagnóstico de esteatosis hepática por métodos clínicos, bioquímicos y por imágenes. 54(1). 37–46. 8 indexed citations
4.
Gámez, Juan Manuel Criado, Giselle Adriana Abruzzese, Gloria Edith Cerrone, et al.. (2016). Síndrome de ovario poliquístico: fenotipos y enfermedad cardiovascular. 53(4). 149–156. 1 indexed citations
5.
Abruzzese, Giselle Adriana, Juan Manuel Criado Gámez, Mabel Graffigna, et al.. (2016). Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome. Hormone and Metabolic Research. 49(1). 23–29. 54 indexed citations
6.
Graffigna, Mabel, et al.. (2014). Ten years cardiovascular risk estimation according to Framingham score and non HDL-cholesterol in blood donors. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 9(1). 24–27. 6 indexed citations
7.
Moraes, Augusto César Ferreira de, et al.. (2013). Prevalence of cardiovascular risk factors among Latin American adolescents: a multilevel analysis. Journal of Human Hypertension. 28(3). 206–209. 4 indexed citations
8.
Graffigna, Mabel, et al.. (2012). [Triglycerides/HDL-cholesterol ratio: in adolescents without cardiovascular risk factors].. PubMed. 62(2). 167–71. 8 indexed citations
9.
Tellechea, Mariana L., Damián Oscar Muzzio, Susana Belli, et al.. (2012). Association between β2‐adrenoceptor (ADRB2) haplotypes and insulin resistance in PCOS. Clinical Endocrinology. 78(4). 600–606. 9 indexed citations
10.
Graffigna, Mabel, et al.. (2011). Role of -675 4G/5G in the Plasminogen Activator Inhibitor-1 Gene and -308G/A Tumor Necrosis Factor-α Gene Polymorphisms in Obese Argentinean Patients. Genetic Testing and Molecular Biomarkers. 16(5). 372–375. 3 indexed citations
11.
12.
Graffigna, Mabel, et al.. (2010). Síndrome metabólico y riesgo cardiovascular en estudiantes adolescentes de la ciudad de Buenos Aires. 47(2). 14–20.
13.
Lucero, Diego, Valeria Zago, Graciela López, et al.. (2010). Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome?. Clinica Chimica Acta. 412(7-8). 587–592. 25 indexed citations
14.
Lucero, Diego, Valeria Zago, Graciela López, et al.. (2010). Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome. Clinica Chimica Acta. 412(1-2). 143–147. 30 indexed citations
15.
Belli, Susana, et al.. (2010). Relationship between 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene and obesity in Argentinian Hispanic adults. Blood Coagulation & Fibrinolysis. 21(2). 196–198. 1 indexed citations
16.
Graffigna, Mabel, et al.. (2009). [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].. PubMed. 39(1). 30–7. 5 indexed citations
17.
Larrañaga, Gabriela de, et al.. (2007). Plasma Plasminogen Activator Inhibitor-1 Levels and Nonalcoholic Fatty Liver in Individuals With Features of Metabolic Syndrome. Clinical and Applied Thrombosis/Hemostasis. 14(3). 319–324. 12 indexed citations
18.
Belli, Susana, Mabel Graffigna, Adriana Oneto, et al.. (2004). Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome. Fertility and Sterility. 81(3). 624–629. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Alice Neves Bordallo Breakdown of academic impact, for papers by Cynthia Lamendola Breakdown of academic impact, for papers by H Benencia Breakdown of academic impact, for papers by Rüştü Serter Breakdown of academic impact, for papers by Luděk Čížek Breakdown of academic impact, for papers by Sawaek Weerakiet Breakdown of academic impact, for papers by Rosanna Suriano Breakdown of academic impact, for papers by Jianhua Han Breakdown of academic impact, for papers by Jiann‐Loung Hwang Breakdown of academic impact, for papers by Jan Neuman
Rankless by CCL
2026